Hans‐Jürgen Wester

25.9k total citations · 6 hit papers
312 papers, 18.8k citations indexed

About

Hans‐Jürgen Wester is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Hans‐Jürgen Wester has authored 312 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 193 papers in Radiology, Nuclear Medicine and Imaging, 104 papers in Pulmonary and Respiratory Medicine and 102 papers in Oncology. Recurrent topics in Hans‐Jürgen Wester's work include Radiopharmaceutical Chemistry and Applications (137 papers), Prostate Cancer Treatment and Research (77 papers) and Medical Imaging Techniques and Applications (50 papers). Hans‐Jürgen Wester is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (137 papers), Prostate Cancer Treatment and Research (77 papers) and Medical Imaging Techniques and Applications (50 papers). Hans‐Jürgen Wester collaborates with scholars based in Germany, United States and Netherlands. Hans‐Jürgen Wester's co-authors include Markus Schwaiger, Margret Schottelius, Horst Kessler, Johannes Notni, Roland Haubner, Ambros J. Beer, Matthias Eiber, Tobias Maurer, Wolfgang Weber and Jakub Šimeček and has published in prestigious journals such as Angewandte Chemie International Edition, Accounts of Chemical Research and Blood.

In The Last Decade

Hans‐Jürgen Wester

307 papers receiving 18.6k citations

Hit Papers

Diagnostic Efficacy of 68... 2015 2026 2018 2022 2015 2017 2017 2015 2016 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diagnostic Efficacy of 68 Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer
    2015 595 citations Isabel Rauscher, Hans‐Jürgen Wester et al. profile →
  2. 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
    2017 567 citations Hans‐Jürgen Wester, Ken Herrmann et al. European Journal of Nuclear Medicine and Molecular Imaging profile →
  3. A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins
    2017 445 citations Hans‐Jürgen Wester, Horst Kessler et al. profile →
  4. 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
    2015 419 citations Margret Schottelius, Markus Schwaiger et al. Journal of Nuclear Medicine profile →
  5. Simultaneous 68Ga-PSMA HBED-CC PET/MRI Improves the Localization of Primary Prostate Cancer
    2016 418 citations Isabel Rauscher, Ambros J. Beer et al. profile →
  6. 177Lu-Labeled Prostate-Specific Membrane Antigen Radioligand Therapy of Metastatic Castration-Resistant Prostate Cancer: Safety and Efficacy
    2016 397 citations Martina Wirtz, Margret Schottelius et al. Journal of Nuclear Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans‐Jürgen Wester Germany 74 10.7k 6.7k 5.3k 3.7k 2.5k 312 18.8k
Mark X. Sliwkowski United States 52 9.8k 0.9× 3.4k 0.5× 14.5k 2.7× 9.9k 2.7× 1.2k 0.5× 111 21.9k
Neil H. Bander United States 64 5.5k 0.5× 7.4k 1.1× 5.3k 1.0× 5.2k 1.4× 400 0.2× 230 15.6k
Michael R. Zalutsky United States 62 8.3k 0.8× 2.6k 0.4× 3.3k 0.6× 3.1k 0.8× 374 0.2× 360 13.4k
Walter Mier Germany 61 6.6k 0.6× 4.7k 0.7× 5.8k 1.1× 3.8k 1.0× 200 0.1× 243 15.1k
Uwe Haberkorn Germany 91 17.4k 1.6× 13.4k 2.0× 12.3k 2.3× 4.6k 1.2× 273 0.1× 517 31.2k
Roger Schibli Switzerland 63 9.2k 0.9× 3.4k 0.5× 4.8k 0.9× 3.3k 0.9× 240 0.1× 375 14.8k
Ambros J. Beer Germany 48 5.8k 0.5× 4.0k 0.6× 1.8k 0.3× 1.3k 0.3× 1.3k 0.5× 225 9.9k
David A. Reardon United States 89 5.6k 0.5× 7.3k 1.1× 8.7k 1.6× 10.4k 2.8× 651 0.3× 560 34.0k
Steven Wong United States 17 6.6k 0.6× 2.0k 0.3× 11.5k 2.2× 6.6k 1.8× 707 0.3× 36 16.0k
Wendy J. Levin United States 14 6.6k 0.6× 2.0k 0.3× 11.5k 2.2× 6.5k 1.8× 706 0.3× 36 15.8k

Countries citing papers authored by Hans‐Jürgen Wester

Since Specialization
Citations

This map shows the geographic impact of Hans‐Jürgen Wester's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Jürgen Wester with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Jürgen Wester more than expected).

Fields of papers citing papers by Hans‐Jürgen Wester

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Jürgen Wester. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Jürgen Wester. The network helps show where Hans‐Jürgen Wester may publish in the future.

Co-authorship network of co-authors of Hans‐Jürgen Wester

This figure shows the co-authorship network connecting the top 25 collaborators of Hans‐Jürgen Wester. A scholar is included among the top collaborators of Hans‐Jürgen Wester based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans‐Jürgen Wester. Hans‐Jürgen Wester is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Beck, Roswitha, Alexander Dierks, Christian H. Pfob, et al.. (2023). Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [68Ga]Ga-DOTA-CCK-66 PET/CT in 2 Patients with Medullary Thyroid Cancer. Journal of Nuclear Medicine. 65(1). 33–39. 8 indexed citations
3.
Konrad, Matthias, et al.. (2022). Optimization of the Pharmacokinetic Profile of [99mTc]Tc-N4-Bombesin Derivatives by Modification of the Pharmacophoric Gln-Trp Sequence. Pharmaceuticals. 15(9). 1133–1133. 6 indexed citations
4.
Konrad, Matthias, Theresa Baumeister, Roland M. Schmid, et al.. (2022). CXCR4 peptide-based fluorescence endoscopy in a mouse model of Barrett’s esophagus. EJNMMI Research. 12(1). 2–2. 13 indexed citations
5.
Lawal, Ismaheel O., Gbenga O. Popoola, Johncy Mahapane, et al.. (2020). [68Ga]Ga-Pentixafor for PET Imaging of Vascular Expression of CXCR-4 as a Marker of Arterial Inflammation in HIV-Infected Patients: A Comparison with 18F[FDG] PET Imaging. Biomolecules. 10(12). 1629–1629. 13 indexed citations
6.
Makowski, Marcus R., Christoph Rischpler, Ullrich Ebersberger, et al.. (2020). Multiparametric PET and MRI of myocardial damage after myocardial infarction: correlation of integrin αvβ3 expression and myocardial blood flow. European Journal of Nuclear Medicine and Molecular Imaging. 48(4). 1070–1080. 30 indexed citations
7.
Mayerhoefer, Marius E., Alexander Haug, Ulrich Jäger, et al.. (2020). In Human Visualization of Ibrutinib-Induced CLL Compartment Shift. Cancer Immunology Research. 8(8). 984–989. 8 indexed citations
8.
Kroenke, Markus, Thomas Horn, Jan C. Peeken, et al.. (2020). Matched-Pair Comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non–Tumor-Related Uptake and Tumor Positivity. Journal of Nuclear Medicine. 62(8). 1082–1088. 45 indexed citations
9.
Wirtz, Martina, Alexander Schmidt, Margret Schottelius, et al.. (2018). Synthesis and in vitro and in vivo evaluation of urea-based PSMA inhibitors with increased lipophilicity. EJNMMI Research. 8(1). 84–84. 28 indexed citations
10.
Fang, Hsin‐Yu, Margret Schottelius, Haibo Liu, et al.. (2017). CXCR4 Is a Potential Target for Diagnostic PET/CT Imaging in Barrett's Dysplasia and Esophageal Adenocarcinoma. Clinical Cancer Research. 24(5). 1048–1061. 35 indexed citations
11.
Merseburger, Axel S., Sebastian Schmuck, Tobias L. Roß, et al.. (2017). 68Ga-PSMA PET/CT Imaging Predicting Intraprostatic Tumor Extent, Extracapsular Extension and Seminal Vesicle Invasion Prior to Radical Prostatectomy in Patients with Prostate Cancer. Nuclear Medicine and Molecular Imaging. 51(4). 314–322. 51 indexed citations
12.
Nonnekens, Julie, Kristell L.S. Chatalic, Janneke D.M. Molkenboer‐Kuenen, et al.. (2017). 213 Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer Xenografts. Cancer Biotherapy and Radiopharmaceuticals. 32(2). 67–73. 52 indexed citations
13.
Lapa, Constantin, Katharina Lückerath, Camelia Maria Monoranu, et al.. (2016). 68Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma. Theranostics. 6(3). 428–434. 88 indexed citations
14.
Poschenrieder, Andreas, Margret Schottelius, Markus Schwaiger, Horst Kessler, & Hans‐Jürgen Wester. (2016). The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity. EJNMMI Research. 6(1). 36–36. 32 indexed citations
15.
Friedrich, Lars, Iina Laitinen, Martin Schlapschy, et al.. (2014). High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation. mAbs. 7(1). 96–109. 61 indexed citations
16.
Förster, Stefan, Timo Grimmer, Isabelle Miederer, et al.. (2011). Regional Expansion of Hypometabolism in Alzheimer's Disease Follows Amyloid Deposition with Temporal Delay. Biological Psychiatry. 71(9). 792–797. 75 indexed citations
17.
Langer, Rupert, Katja Ott, Katja Specht, et al.. (2008). Protein Expression Profiling in Esophageal Adenocarcinoma Patients Indicates Association of Heat-Shock Protein 27 Expression and Chemotherapy Response. Clinical Cancer Research. 14(24). 8279–8287. 49 indexed citations
18.
Decristoforo, Clemens, Janette Carlsen, Marco Rupprich, et al.. (2008). 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of αvβ3 integrin expression. European Journal of Nuclear Medicine and Molecular Imaging. 35(8). 1507–1515. 133 indexed citations
19.
Wester, Hans‐Jürgen, et al.. (2004). Radiolabeled Carbohydrated Somatostatin Analogs: A Review of the Current Status. Cancer Biotherapy and Radiopharmaceuticals. 19(2). 231–244. 30 indexed citations
20.
Guhlke, Stefan, Hans‐Jürgen Wester, Christian Bruns, & G. Stöcklin. (1994). (2-[18F]fluoropropionyl-(d)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: Synthesis, radiolabeling, in vitro validation and biodistribution in mice. Nuclear Medicine and Biology. 21(6). 819–825. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark X. Sliwkowski Breakdown of academic impact, for papers by Neil H. Bander Breakdown of academic impact, for papers by Michael R. Zalutsky Breakdown of academic impact, for papers by Walter Mier Breakdown of academic impact, for papers by Uwe Haberkorn Breakdown of academic impact, for papers by Roger Schibli Breakdown of academic impact, for papers by Ambros J. Beer Breakdown of academic impact, for papers by David A. Reardon Breakdown of academic impact, for papers by Steven Wong Breakdown of academic impact, for papers by Wendy J. Levin
Rankless by CCL
2026